| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.2 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.04 | 0.2 |